FDA Working "Rapidly" To Grant Emergency Use Of Pfizer's COVID-19 Vaccine

WASHINGTON, D.C. (CBSNEWS.COM) — The U.S. Food and and Drug Administration said Friday it will work quickly to authorize Pfizer's COVID-19 vaccine for emergency use after an advisory panel voted in favor of it.

In a statement FDA Commissioner Stephen Hahn and Peter Marks, director of the FDA's Center for Biologics Evaluation and Research, said, "Following yesterday's [Dec. 10] positive advisory committee meeting outcome regarding the Pfizer-BioNTech COVID-19 vaccine, the U.S. Food and Drug Administration has informed the sponsor that it will rapidly work toward finalization and issuance of an emergency use authorization."

♦♦♦ Click Here To Read The Latest On The Story On cbsnews.com ♦♦♦

Read more
f

We and our partners use cookies to understand how you use our site, improve your experience and serve you personalized content and advertising. Read about how we use cookies in our cookie policy and how you can control them by clicking Manage Settings. By continuing to use this site, you accept these cookies.